Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Social Media for Colorectal Cancer Screening

16. marts 2020 opdateret af: Nancy Baxter, Unity Health Toronto

Utilizing Social Media for Colorectal Cancer Screening: An Innovative Randomized Controlled Trial

Using social media for health promotion is an innovative and emerging approach but remains relatively unexplored in cancer screening. Uptake of colorectal cancer (CRC) screening remains low and standard methods of reaching out are expensive with limited impact. The objective of this study is to conduct a cluster randomized controlled trial (RCT) to test the effectiveness of social media messages for CRC screening on screening intention (primary outcome). The results of this trial will be of interest to Cancer Care Ontario and are likely to be taken up by other screening programs looking for innovative and novel ways to increase screening participation. The study results will be easily translatable identifying the most compelling CRC screening messages while the approach can easily be translated to other cancer disease sites with screening programs.

Studieoversigt

Status

Ukendt

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

The investigators will conduct a cluster randomized controlled trial (RCT) in Facebook users (aged 50+) in Ontario. Randomization will be done at the level of the forward sortation area (FSA) - the first three characters of the postal code. All FSAs in Ontario will be randomized to one of four study arms - users assigned to each arm will receive one of the social media messages. If users click on the message, a webpage with further information on screening will appear and participants will be asked to indicate intention to get screened for CRC. The primary outcome will be intention to screen and secondary outcomes will include other engagement metrics such as reach, cost-per-click, click-through rates, number of likes, number of impressions, and post comments.

This study will inform the feasibility of using social media for CRC screening and identify the most compelling CRC screening messages for the screen-eligible population.

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

56000

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

50 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Facebook users in Ontario who are older than 50 years of age

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Tredobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Message #1
This arm will receive one of three social media messages that is preferred by our target population through focus groups that are being conducted as part of a previous study.
Andet: Social media message #1
Social media message promoting colorectal cancer screening
Aktiv komparator: Message #2
This arm will receive the second social media message that is preferred by our target population as identified from our previous focus group study.
Andet: Social media message #2
A different social media message promoting colorectal cancer screening
Aktiv komparator: Message #3
This arm will receive the third social media message that is preferred by our target population as identified from our previous focus group study.
Andet: Social media message #3
A different social media message promoting colorectal cancer screening
Aktiv komparator: Tailored Arm
This arm will receive social media messages that will be tailored by one of the following variables: gender (men/women), age (younger/older), location (urban/rural), or social economic status (level of education). Testing to be conducted in a previous study will identify the variable that messages are tailored by.
Andet: Tailored social media messages
Tailored social media messages promoting colorectal cancer screening.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Screening intention
Tidsramme: From date of randomization to end of the study at 3 months
The proportion of individuals in each arm that click on the ad and confirm their intention to get screened for CRC
From date of randomization to end of the study at 3 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Cost-per-click
Tidsramme: From date of randomization to end of the study at 3 months
The average cost per link click calculated as the total amount spent on the ad campaign divided by total number of link clicks
From date of randomization to end of the study at 3 months
Click-through-rate
Tidsramme: From date of randomization to the end of study at 3 months
Percentage of times that individuals saw the ads and performed a click
From date of randomization to the end of study at 3 months
Number of likes
Tidsramme: At the end of the study period at 3 months
Total number of Facebook likes for each ad
At the end of the study period at 3 months
Number of impressions
Tidsramme: At the end of the study period at 3 months
Number of times that each ad was on screen
At the end of the study period at 3 months
Post comments
Tidsramme: At the end of the study period at 3 months
Number of comments on each ad
At the end of the study period at 3 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Unity Health Toronto

Samarbejdspartnere

Canadian Institutes of Health Research (CIHR)
Applied Health Research Centre

Efterforskere

  • Ledende efterforsker: Nancy N. Baxter, MD, FRCSC, FACS, PhD, Unity Health Toronto

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Forventet)

1. august 2020

Primær færdiggørelse (Forventet)

31. oktober 2020

Studieafslutning (Forventet)

31. oktober 2020

Datoer for studieregistrering

Først indsendt

3. marts 2020

Først indsendt, der opfyldte QC-kriterier

3. marts 2020

Først opslået (Faktiske)

5. marts 2020

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. marts 2020

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

16. marts 2020

Sidst verificeret

1. marts 2020

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 20-005

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data will not be available to share because the study results will not be at the individual-level and therefore this is not applicable.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Kolorektal cancer

Kliniske forsøg med Social media message #1

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Cameroon

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

3
Abonner